Tagged with Medicare
HHS Announced Key Dates for the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
ahs The Inflation Reduction Act allows Medicare to negotiate directly with drug manufacturers for the prices of prescription drugs. CMS will publish the first 10 Medicare Part D drugs selected for the Medicare Drug Price Negotiation Program. The negotiated maximum fair prices for these drugs will be announced by September 1, 2024. Prices…
AHA Commended CMS for Increasing Oversight of Medicare Advantage Plans
The AHA stated that CMS had taken significant steps to increase oversight of Medicare Advantage plans. According to AHA, the CMS is working on new proposals. These proposal will tackle authorization barriers, and excessive marketing practices, among other issues. The AHA mentioned they would continue to carefully review the proposed rule and support…
Four Health Policy Takeaways in the Inflation Reduction Act
The Inflation Reduction Act (IRA) makes some health changes in cutting prescription drug costs, lowering health care costs for Americans, and defeating special interests. This law allows the government to negotiate prices for some drugs. Previously this was prohibited. Experts say regulating the bill will have a significant impact on providers. The House passed the…
CMS Issued Hospital IPPS Final Rule for Fiscal Year 2023
CMS Final Rule updated the IPPS rates by 2.6% in FY 2023 compared to FY 2022. The rule will be effective on October 1, 2022. AHA thanked CMS for increasing the IPPS instead of cutting them as proposed. However, the association said the update still falls short regarding the healthcare needs during these times. On…
